# Gilly Biotechnologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gilly-biotechnologies

- Industry: Biotechnology
- Headquarters: US
- Latest round: Seed (Aug 8, 2025)
- Investors on record: 1

## About

Based in San Francisco, California, USA, and incorporated in March 2025, Gilly Biotechnologies, Inc. operates as a venture-backed biotech company currently in stealth mode. It focuses on developing innovative solutions within the life sciences sector, supported by accelerators and early-stage investors. The company has not publicly disclosed its product portfolio, as it operates in stealth mode. However, its positioning suggests a focus on advanced biotechnological applications, likely involving therapeutic or diagnostic innovations. Currently, Gilly Biotechnologies does not generate commercial revenue and relies on venture capital funding for operations. Its future revenue model is expected to include product commercialization and strategic partnerships in biotech markets. Gilly Biotechnologies aims to scale its operations post-stealth phase by leveraging investor networks and accelerating R&D. Plans likely include expanding into clinical development and forming alliances to bring its innovations to market.

## Funding rounds

- Seed, Aug 8, 2025 — SOSV

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed